Respiratory

Latest News

AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month
AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month

March 18th 2024

AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.

Exploring Electronic Cigarettes’ Success Among Other Tobacco Cessation Methods
Exploring Electronic Cigarettes’ Success Among Other Tobacco Cessation Methods

March 8th 2024

Rx Roundup: Quiz of the Week — March 8, 2024
Rx Roundup: Quiz of the Week — March 8, 2024

March 8th 2024

Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month
Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month

March 7th 2024

Latest CME Events & Activities

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC

2 Credits / Oncology, Pulmonology/Respiratory

View More

Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies

3.0 Credits / Pulmonology/Respiratory

View More

Targeted Therapies for Non-Small Cell Lung Cancer With ROS1 or KRAS Mutations and the Impact of Pharmacists’ Care

1.0 Credit / Oncology, Pulmonology/Respiratory

View More

Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective

1.5 Credits / Pulmonology/Respiratory

View More

Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling

1.0 Credit / Infectious Diseases, Pulmonology/Respiratory

View More

Exploring Recent Advances in the Treatment of COPD: An Update for Pharmacists

0.75 Credit / Pulmonology/Respiratory

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Novel Therapeutic Approaches for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer: An Oncology Pharmacy Perspective

1.0 Credit / Oncology, Pulmonology/Respiratory

View More

Practical Approaches in the Management of Pulmonary Arterial Hypertension: Understanding the Pharmacist’s Role in Personalized Care

1.0 Credit / Pulmonology/Respiratory

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency

1.0 Credit / Pulmonology/Respiratory

View More

Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults

2.0 Credits / Infectious Diseases, Respiratory, Immunization

View More

Integrating Guideline-Driven Protocols Into Evidence-Based Practice to Improve Outcomes in Patients With Pulmonary Arterial Hypertension

1.0 Credit / Respiratory

View More

GASp, Where’s the Amoxicillin? Group A Streptococcus Infections and What Pharmacists Need to Know

1.0 Credit / Pulmonology/Respiratory

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Exploring the GOLD Report Updates and the Value of Patient-Centered Strategies for the Treatment of Chronic Obstructive Pulmonary Disease: Opportunities to Reduce Health Burde...

1.0 Credit / Pulmonology/Respiratory

View More

Exploring the GOLD Report Updates and the Value of Patient-Centered Strategies for the Treatment of Chronic Obstructive Pulmonary Disease: Opportunities to Reduce Health Burde...

1.0 Credit / Pulmonology/Respiratory

View More

More News

© 2024 MJH Life Sciences

All rights reserved.